With the analysis among 49 patents, we discovered top 17 key players by total patent application. BioLineRx Ltd., Merck Sharp & Dohme Corp., Shanghai Laiyi Biopharmaceutical Research & Development Center are dominant in this area. They take 46.94% of the total patent filing.
New Jersey, United States
Patent: 7
Shanghai Shi, China
Patent: 6
WALES, United Kingdom
Patent: 5
Kanagawa-ken, Japan
Patent: 2
No data, please try another search term
With the analysis among related 27 patents applied in the last 5 years. We discover 17 most active companies in this area. The fast-growing BioLineRx Ltd., Merck Sharp & Dohme Corp., Cellbitec SL take 74.07% of patent filing during this period.
New Jersey, United States
Patent: 7
ANDALUSIA, Spain
Patent: 3
Universita' Degli Studi di Roma La Sapienza
WALES, United Kingdom
Patent: 1
Beijing Shi, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
With the analysis among related 27 patents in last 5 years, we discover 14 new entrants. BioLineRx Ltd., Merck Sharp & Dohme Corp., Cellbitec SL are the most active new entrants in this area.
New Jersey, United States
Patent: 7
ANDALUSIA, Spain
Patent: 3
Universita' Degli Studi di Roma La Sapienza
Beijing Shi, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
New York, United States
Patent: 1
With the analysis among 27 patents, we discovered top 9 universities and scientific research institutions by total patent application. The Johns Hopkins University, Shanghai Jiao Tong University, University of Nebraska are dominant in this area. They take 37.04% of the total patent filing.
Shanghai Shi, China
Patent: 3
Nebraska, United States
Patent: 2
Central Region, Singapore
Patent: 1
New York, United States
Patent: 1
California, United States
Patent: 1
Central Region, Singapore
Patent: 1